The benefits of Omega-3 supplementation are well known, however, the challenge to achieve optimum absorption remains. It is often suggested to be taken with a fatty meal, which is not always convenient or possible, for many people.
Improving efficacy and reducing dose size, for both consumers and manufacturers is therefore essential.
Studies have shown that AquaCelle® Omega-3 with its high active load, increases absorption by up to 600%, dramatically improving EPA and DHA uptake. Reduced dose size supports better consumer compliance, while addressing the efficacy issues of fish oils.
AquaCelle® formulations have a unique ability to reduce fishy reflux, a leading cause of consumer non-compliance.
